TOP
Financial Results for FYE March 2018 and New Medium-term Business Plan
Agenda
1. Overview of STEP UP 17
2. The Meiji Group 2026 Vision
3. The New Medium-term Business Plan
Key Strategies
Food: Expanding Yogurt, Chocolate, and Nutritional Products
Food: Cultivate Future Growth Drivers
Pharma: Maximize Product Value in Core Domains and Enhance Presence
Pharma: Expand Sales of Generic Drugs and Accelerate Biosimilar Development to Drive Growth
Food: Launch High Value-added Products, Invest Intensely in Overseas Business
Pharma: Expand CMO/CDMO Business at Medreich
Food: Continue Structural Reforms to Improve Productivity
Food: Improve Profitability in Milk Business
Pharma: Structural Reform and Platform Development to Grow Income from Overseas Agricultural Chemicals and Veterinary Drug Business
KPIs - The New Medium-term Business Plan (1)
KPIs - The New Medium-term Business Plan (2)
Use of Cash Flows
4. Outlook for the FYE March 2019
Appendix: Financial data
Appendix: Topics
Back cover
Numerical targets for 2020 Medium-Term Business Plan
